These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23983139)

  • 1. Gastric pre-processing is an important determinant of the ability of medium-chain lipid solution formulations to enhance oral bioavailability in rats.
    Lee KW; Porter CJ; Boyd BJ
    J Pharm Sci; 2013 Nov; 102(11):3957-65. PubMed ID: 23983139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug.
    Lee KW; Porter CJ; Boyd BJ
    J Pharm Sci; 2013 Feb; 102(2):565-78. PubMed ID: 23242691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
    Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
    Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid absorption triggers drug supersaturation at the intestinal unstirred water layer and promotes drug absorption from mixed micelles.
    Yeap YY; Trevaskis NL; Porter CJ
    Pharm Res; 2013 Dec; 30(12):3045-58. PubMed ID: 23793990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.
    Porter CJ; Kaukonen AM; Taillardat-Bertschinger A; Boyd BJ; O'Connor JM; Edwards GA; Charman WN
    J Pharm Sci; 2004 May; 93(5):1110-21. PubMed ID: 15067688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations.
    Paulus F; Bauer-Brandl A; Stappaerts J; Holm R
    Eur J Pharm Sci; 2024 Jan; 192():106634. PubMed ID: 37951315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
    Feeney OM; Williams HD; Pouton CW; Porter CJ
    J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
    Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
    Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of cinnarizine in dogs: effect of SNEDDS loading level and correlation with cinnarizine solubilization during in vitro lipolysis.
    Larsen AT; Åkesson P; Juréus A; Saaby L; Abu-Rmaileh R; Abrahamsson B; Østergaard J; Müllertz A
    Pharm Res; 2013 Dec; 30(12):3101-13. PubMed ID: 23949249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability.
    Alhnan MA; Murdan S; Basit AW
    Int J Pharm; 2011 Sep; 416(1):55-60. PubMed ID: 21679756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
    Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
    Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
    Grove M; Müllertz A; Nielsen JL; Pedersen GP
    Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
    Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
    Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
    Dahan A; Hoffman A
    Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.
    Porter CJ; Kaukonen AM; Boyd BJ; Edwards GA; Charman WN
    Pharm Res; 2004 Aug; 21(8):1405-12. PubMed ID: 15359575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
    Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digestion behavior, in vitro and in vivo bioavailability of cannabidiol in emulsions stabilized by whey protein-maltodextrin conjugate: Impact of carrier oil.
    Wang C; Dong C; Lu Y; Freeman K; Wang C; Guo M
    Colloids Surf B Biointerfaces; 2023 Mar; 223():113154. PubMed ID: 36708645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
    Nguyen TH; Hanley T; Porter CJ; Boyd BJ
    J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats--effect of medium and long chain triglycerides.
    Grove M; Pedersen GP; Nielsen JL; Müllertz A
    J Pharm Sci; 2005 Aug; 94(8):1830-8. PubMed ID: 15986460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.